PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults with MCI and Early Stage AD

PATH-Pain:一种基于初级保健的心理社会干预措施,可改善患有 MCI 和早期 AD 的老年人的认知和抑郁结果

基本信息

  • 批准号:
    10682594
  • 负责人:
  • 金额:
    $ 68.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-15 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

This MPI R01 combines the expertise of the Departments of Psychiatry, Neurology, and Internal Medicine at Weill Cornell Medicine to address MCI (mild cognitive impairment) and early stage AD/ADRD in patients with comorbid chronic pain and depression. We propose to test whether Problem Adaptation Therapy for Pain (PATH-Pain), a novel primary-care based psychosocial intervention designed to reduce stress in MCI and early stage AD/ADRD patients with comorbid depression and pain, has better cognitive, affective, and functional outcomes than Attention Control Usual Care. PATH-Pain is an easy-to-administer psychosocial intervention designed to improve emotion regulation and reduce stress in older adults with MCI or early stage AD/ADRD, chronic pain, and depression. To reduce stress, PATH-Pain aims to: a) reduce negative emotions associated with pain and pain-related disability; b) reduce negative emotions that interfere with pain treatment (e.g., hopelessness, helplessness); c) increase positive emotions and increase engagement in pleasurable activities; d) help patients identify addressable problems in their lives and try to find the best possible solution to these problems; e) reduce interpersonal tension between patients and family members, caregivers, and friends; and f) shift attention during experiences of pain to reduce pain intensity. To achieve these aims, PATH-Pain employs emotion regulation, problem solving, and behavioral activation techniques. In our preliminary study, PATH-Pain participants showed high acceptability and treatment satisfaction with the intervention. Based on our power analysis, we will randomize 100 older adults (60 years and older) with MCI or early stage dementia (probable or possible Alzheimer’s Disease), comorbid depression, and chronic pain to 8 weekly in-office sessions and 6 monthly phone (3 individual and 3 group) sessions of PATH-Pain vs. Attention Control Usual Care in 4 primary care sites. The Attention Control Usual Care arm consists of Usual Care, a pamphlet on pain and depression, and a structured interview of the same duration as each PATH-Pain session. The structured interview aims to control for attention and time, and will consist of general questions regarding health habits and other non-medical topics unrelated to cognitive impairment, pain, and depression. The investigators have shown evidence of feasibility of recruitment, retention, and assessment procedures for the proposed study. Assessments will be performed at baseline, and weeks 5 (no cognitive outcomes), 9, 24 (no cognitive outcomes), 36, and 52 by research assistants unaware of the study hypotheses and the participants’ randomization status. PATH-Pain will be administered by certified mental health workers and the Attention-Control sessions will be administered by a non-clinician team member experienced in structured interviews.
该 MPI R01 结合了威尔康奈尔医学院精神病学、神经病学和内科的专业知识,旨在解决患有慢性疼痛和抑郁症的患者的 MCI(轻度认知障碍)和早期 AD/ADRD 问题。疼痛适应疗法 (PATH-Pain) 是一种基于初级保健的新型心理社会干预措施,旨在减轻患有抑郁症和疼痛的 MCI 和早期 AD/ADRD 患者的压力,具有更好的认知、情感和功能结果优于注意力控制日常护理。 PATH-Pain 是一种易于实施的心理社会干预措施,旨在改善患有 MCI 或早期 AD/ADRD、慢性疼痛和抑郁症的老年人的情绪调节和减轻压力。为了减轻压力,PATH-Pain 旨在:a)减少与疼痛和疼痛相关的残疾相关的负面情绪; b) 减少干扰疼痛治疗的负面情绪(例如绝望、无助); c) 增加积极情绪并增加对愉快活动的参与 d) 帮助患者识别可解决的问题;并尝试找到解决这些问题的最佳方法; e) 减少患者与家人、护理人员和朋友之间的人际关系紧张;以及 f) 在经历疼痛时转移注意力以减轻疼痛强度。 -疼痛采用情绪调节、问题解决和行为激活技术,PATH-Pain 参与者对干预表现出很高的接受度和治疗满意度。 根据我们的功效分析,我们将 100 名患有 MCI 或早期痴呆症(可能或可能患有阿尔茨海默病)、共病抑郁症和慢性疼痛的老年人(60 岁及以上)随机分组,接受每周 8 次的门诊治疗和每月 6 次电话咨询(在 4 个初级保健中心进行 3 次个人和 3 次小组的 PATH-疼痛与注意力控制日常护理课程 注意力控制日常护理部门包括日常护理、关于疼痛和注意力的小册子。结构化访谈的目的是控制注意力和时间,并将包括有关健康习惯和其他与认知障碍、疼痛无关的非医学主题的一般问题。研究人员已经证明了拟议研究的招募、保留和评估程序的可行性。评估将在第 5 周(无认知结果)、第 9 周、第 24 周(无认知结果)、第 36 周进行。 52 名研究助理不了解研究假设和参与者的随机化状态的 PATH-Pain 将由经过认证的心理健康工作者进行,注意力控制课程将由具有结构化访谈经验的非临床医生团队成员进行。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DIMITRIS N KIOSSES其他文献

DIMITRIS N KIOSSES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DIMITRIS N KIOSSES', 18)}}的其他基金

A Mobile Intervention for Suicide Prevention For Middle-aged And Older Adults After a Suicide-Related Hospitalization
中老年人因自杀住院后预防自杀的移动干预
  • 批准号:
    10356268
  • 财政年份:
    2022
  • 资助金额:
    $ 68.54万
  • 项目类别:
A Mobile Intervention for Suicide Prevention For Middle-aged And Older Adults After a Suicide-Related Hospitalization
中老年人因自杀住院后预防自杀的移动干预
  • 批准号:
    10559578
  • 财政年份:
    2022
  • 资助金额:
    $ 68.54万
  • 项目类别:
PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults with MCI and Early Stage AD
PATH-Pain:一种基于初级保健的心理社会干预措施,可改善患有 MCI 和早期 AD 的老年人的认知和抑郁结果
  • 批准号:
    10461920
  • 财政年份:
    2021
  • 资助金额:
    $ 68.54万
  • 项目类别:
PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults with MCI and Early Stage AD
PATH-Pain:一种基于初级保健的心理社会干预措施,可改善患有 MCI 和早期 AD 的老年人的认知和抑郁结果
  • 批准号:
    10297969
  • 财政年份:
    2021
  • 资助金额:
    $ 68.54万
  • 项目类别:
PATH-Pain: A Primary Care-Based Psychosocial Intervention To Improve Cognitive and Depression Outcomes in Older Adults with MCI and Early Stage AD
PATH-Pain:一种基于初级保健的心理社会干预措施,可改善患有 MCI 和早期 AD 的老年人的认知和抑郁结果
  • 批准号:
    10297969
  • 财政年份:
    2021
  • 资助金额:
    $ 68.54万
  • 项目类别:
Problem Adaptation Therapy for Mild Cognitive Impairment with Depression
轻度认知障碍抑郁症的问题适应疗法
  • 批准号:
    9196618
  • 财政年份:
    2016
  • 资助金额:
    $ 68.54万
  • 项目类别:
A Novel Cognitive Reappraisal Intervention for Suicide Prevention
预防自杀的新型认知重评干预措施
  • 批准号:
    10478388
  • 财政年份:
    2016
  • 资助金额:
    $ 68.54万
  • 项目类别:
Problem Adaptation Therapy for Mild Cognitive Impairment with Depression
轻度认知障碍抑郁症的问题适应疗法
  • 批准号:
    9335774
  • 财政年份:
    2016
  • 资助金额:
    $ 68.54万
  • 项目类别:
A Novel Cognitive Reappraisal Intervention for Suicide Prevention
预防自杀的新型认知重评干预措施
  • 批准号:
    10005464
  • 财政年份:
    2016
  • 资助金额:
    $ 68.54万
  • 项目类别:
A Novel Cognitive Reappraisal Intervention for Suicide Prevention
预防自杀的新型认知重评干预措施
  • 批准号:
    9164519
  • 财政年份:
    2016
  • 资助金额:
    $ 68.54万
  • 项目类别:

相似国自然基金

巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
  • 批准号:
    82304503
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
  • 批准号:
    82374256
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
  • 批准号:
    82300771
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
  • 批准号:
    82374209
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting P21 positive senescent cells for alleviating TMJ degeneration
靶向 P21 阳性衰老细胞减轻 TMJ 变性
  • 批准号:
    10892710
  • 财政年份:
    2023
  • 资助金额:
    $ 68.54万
  • 项目类别:
Evaluating the impacts of sea level rise on migration and wellbeing in coastal communities
评估海平面上升对沿海社区移民和福祉的影响
  • 批准号:
    10723570
  • 财政年份:
    2023
  • 资助金额:
    $ 68.54万
  • 项目类别:
GEMSSTAR PERSPIRE-COPD
GEMSSTAR 出汗-慢性阻塞性肺病
  • 批准号:
    10724784
  • 财政年份:
    2023
  • 资助金额:
    $ 68.54万
  • 项目类别:
Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures
芥子气引起的结膜损伤的机制以及脂质介质作为医疗对策的使用
  • 批准号:
    10882060
  • 财政年份:
    2023
  • 资助金额:
    $ 68.54万
  • 项目类别:
3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
3/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
  • 批准号:
    10711001
  • 财政年份:
    2023
  • 资助金额:
    $ 68.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了